{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Nicholas Riley"}, {"accession": "MS:1000589", "name": "contact email", "value": "riley.nicholasm@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Stanford University"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Carolyn Bertozzi"}, {"accession": "MS:1000589", "name": "contact email", "value": "bertozzi@stanford.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Department of Chemistry, Stanford University Stanford ChEM-H"}]}], "datasetFiles": [{"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/Phospho Sites Combined_Polymer.txt"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/Phospho Combined Stimulated.txt"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/Neutrophil Phospho TMT Data To Upload.xlsx"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_25_NeutStim_IMAC_1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_25_NeutStim_IMAC_2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_25_NeutStim_IMAC_3.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_25_NeutStim_Prot_1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_25_NeutStim_Prot_2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_25_NeutStim_Prot_3.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_24_NeutPolymer_IMAC_1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_24_NeutPolymer_IMAC_2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_24_NeutPolymer_IMAC_3.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_24_NeutPolymer_Prot_1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_24_NeutPolymer_Prot_2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990/2020_11_24_NeutPolymer_Prot_3.raw"}], "description": "Severe cases of coronavirus disease 2019 (COVID-19) are characterized by a hyperinflammatory immune response that leads to numerous complications. Production of proinflammatory neutrophil extracellular traps (NETs) has been suggested to be a key factor in inducing a hyperinflammatory signaling cascade, allegedly causing both pulmonary tissue damage and peripheral inflammation. If true, finding ways to inhibit NET production could provide therapeutic strategies to prevent respiratory damage and death from SARS-CoV-2 related inflammation. Here, we demonstrate that synthetic glycopolymers that activate signaling of the neutrophil checkpoint receptor Siglec-9 suppress NETosis induced by agonists of viral TLR receptors and COVID-19 plasma. Thus, Siglec-9 represents an attractive therapeutic target to curb neutrophilic hyperinflammation in COVID-19.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/07/PXD022990"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD022990"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD022990"}], "instruments": [{"accession": "MS:1002416", "name": "Orbitrap Fusion"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Siglec, NETosis, Neutrophil, SARS-CoV-2, COVID-19"}, {"accession": "MS:1002340", "name": "ProteomeXchange project tag", "value": "Covid-19"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "33469569"}, {"accession": "MS:1002866", "name": "Reference", "value": "Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC, Stanford COVID-19 Biobank, Blish CA, Bertozzi CR. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19. ChemRxiv. 2020"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Synthetic Siglec-9 agonists inhibit neutrophil activation associated with COVID-19"}